Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)
Federico Innocenti(AbbVie (United States)), Kouros Owzar(Duke University), Monica M. Bertagnolli(National Institutes of Health), Yoichi Furukawa(The University of Tokyo), Alexander B. Sibley(Duke University), Charles D. Blanke(SWOG Cancer Research Network), Alan P. Venook(University of California, San Francisco), Heinz‐Josef Lenz(USC Norris Comprehensive Cancer Center), Joel S. Parker(University of North Carolina at Chapel Hill), J. Todd Auman(The University of Texas MD Anderson Cancer Center), Mark J. Ratain(University of Chicago), Fang‐Shu Ou(Mayo Clinic), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Sarah J. Plummer(Cleveland Clinic), Stefanie Howell(University of North Carolina at Chapel Hill), Graham Casey(Cleveland Clinic Lerner College of Medicine), Chen Jiang, Howard L. McLeod(Unknown), Sushant Patil(University of North Carolina at Chapel Hill), Amy S. Etheridge(University of North Carolina at Chapel Hill)
Cited by 27
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k